Patents by Inventor Jay A. Waitz

Jay A. Waitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Micromonospora carbonacea var africana
    Patent number: 4735903
    Abstract: A new variety of Micromonospora carbonacea, namely Micromonospora carbonacea var africana NRRL 15099, ATCC 39149.
    Type: Grant
    Filed: March 27, 1986
    Date of Patent: April 5, 1988
    Assignee: Schering Corporation
    Inventors: Jay A. Waitz, Ann C. Horan
  • Antibiotic 13-384 complex from Micromonospora carbonacea var africana
    Patent number: 4597968
    Abstract: The antibiotic 13-384 complex is elaborated by a new variety of Micromonospora carbonacea; namely Micromonospora carbonacea var africana NRRL 15099.
    Type: Grant
    Filed: June 21, 1984
    Date of Patent: July 1, 1986
    Assignee: Schering Corporation
    Inventors: Jay A. Waitz, Mahesh G. Patel, Joseph A. Marquez, Manohar G. Kalyanpur, Ann C. Horan
  • Broad spectrum antibiotic complex produced by a novel micromonospora
    Patent number: 4440751
    Abstract: The novel antibiotic complex designated hazymicin consisting of eight components, is produced by a novel strain of Micromonospora herein designated Micromonospora echinospora var. challisensis SCC 1411. Also disclosed are the structures of the two components namely, Component 5 and Component 6.
    Type: Grant
    Filed: October 6, 1980
    Date of Patent: April 3, 1984
    Assignee: Schering Corporation
    Inventors: Jay A. Waitz, Joseph A. Marquez, Mahesh G. Patel, Ann C. Horan
  • Amino glycoside antibiotics having antiprotozoal and anthelmintic activity
    Patent number: 4389398
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side affects.
    Type: Grant
    Filed: August 24, 1978
    Date of Patent: June 21, 1983
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay A. Waitz, Mae Counelis, Jay Weinstein
  • Kijanimicin antibiotics and derivatives thereof
    Patent number: 4375542
    Abstract: Actinomadura Kijaniata nov. sp produces a novel antibiotic which we have designated kijanimicin. The antibiotic or cationic salts thereof exhibit anti-acne, antitumor, antimalarial, antibacterial and anti-inflammatory activity.
    Type: Grant
    Filed: October 8, 1980
    Date of Patent: March 1, 1983
    Assignee: Schering Corporation
    Inventors: Jay A. Waitz, Mahesh G. Patel, Ann C. Horan
  • Amino glycoside antibiotics having antiprotozoal activity
    Patent number: 4110439
    Abstract: In the fermentation production of gentamicin C a plurality of additional antibiotic compounds are obtained. Four of these compounds, gentamicin A, gentamicin B, gentamicin B.sub.1 and gentamicin X exhibit significant anti-protozoal and anthelmintic activity while gentamicin B and B.sub.1 have significant antibacterial properties with markedly reduced side effects.
    Type: Grant
    Filed: December 20, 1976
    Date of Patent: August 29, 1978
    Assignee: Schering Corporation
    Inventors: David J. Cooper, Jay A. Waitz, Mae Counelis, Jay Weinstein